Denosumab Biosimilars Versus Denosumab in Postmenopausal Osteoporosis: Updated Systematic Review and Meta-Analysis of Randomized Trials. // Endocrine Practice. – URL: https://www.sciencedirect.com/science/article/pii/S1530891X26012929?dgcid=rss_sd_all
Denosumab Biosimilars Versus Denosumab in Postmenopausal Osteoporosis: Updated Systematic Review and Meta-Analysis of Randomized Trials. Endocrine Practice. https://www.sciencedirect.com/science/article/pii/S1530891X26012929?dgcid=rss_sd_all
“Denosumab Biosimilars Versus Denosumab in Postmenopausal Osteoporosis: Updated Systematic Review and Meta-Analysis of Randomized Trials.” Endocrine Practice.
@article{article44600,
title = {Denosumab Biosimilars Versus Denosumab in Postmenopausal Osteoporosis: Updated Systematic Review and Meta-Analysis of Randomized Trials},
journal = {Endocrine Practice},
url = {https://www.sciencedirect.com/science/article/pii/S1530891X26012929?dgcid=rss_sd_all}
}